<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0012115'>Hepatitis</z:hpo> due to <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">Herpes Simplex</z:e> Virus (HSV) is a rare and severe <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in patients with impaired immunity, as bone marrow transplanted </plain></SENT>
<SENT sid="1" pm="."><plain>The antemortem diagnosis is often difficult to establish because the clinical features are nonspecific </plain></SENT>
<SENT sid="2" pm="."><plain>We report an uncommon cause of <z:hpo ids='HP_0004448'>fulminant hepatic failure</z:hpo> in a neutropenic patient, 14 days after bone marrow transplantation </plain></SENT>
<SENT sid="3" pm="."><plain>HSV-2 <z:hpo ids='HP_0004787'>fulminant hepatitis</z:hpo> occurred during <z:chebi fb="4" ids="2453">acyclovir</z:chebi> prophylactic treatment </plain></SENT>
<SENT sid="4" pm="."><plain>No observation of HSV <z:hpo ids='HP_0012115'>hepatitis</z:hpo> in this context has been reported since prophylaxis is used </plain></SENT>
<SENT sid="5" pm="."><plain>Because of the extremely high apparent mortality associated with HSV <z:hpo ids='HP_0012115'>hepatitis</z:hpo>, and the improved survival noted among the non-marrow-transplant recipients and prolonged survival seen in one marrow transplant recipient, it seems reasonable to urge early and aggressively <z:chebi fb="4" ids="2453">acyclovir</z:chebi> therapy </plain></SENT>
<SENT sid="6" pm="."><plain>A liver biopsy seems to be indispensable in the case of <z:hpo ids='HP_0001399'>hepatic failure</z:hpo> in post-marrow-transplantation in order to make rapidly a diagnosis </plain></SENT>
</text></document>